The purpose of this study is to learn whether women who use progestin-only methods of birth control such as the contraceptive implant (Implanon), the levonorgestral-releasing IUS (Mirena), or depot medroxyprogesterone acetate(DMPA) will experience weight change compared to women using the non-hormonal copper IUC (ParaGard).

The investigators primary hypothesis is that users of DMPA will gain excess weight and increase their BMI above the copper-IUC users; secondarily, the investigators will compare users' data in the LNG-IUC and ENG implant groups to the copper-IUC group.

Inclusion Criteria:

• Patients enrolled in CHOICE between the ages of 18 and 45 who consented to future studies
• Chose levonorgestrel-releasing IUD, copper IUD, the implant, or DMPA as their CHOICE baseline method
• Has baseline height and weight data collected from the on-campus enrollment site
• Able to come back to the on-campus enrollment site for consent process and enrollment activities

Exclusion Criteria:

• Recent history of DMPA use before starting their baseline CHOICE method
• Used current method for less than 11 months or more than 12 months and three weeks

Participants already enrolled in the Contraceptive CHOICE Project will be offered participation during their 12-month follow up window if they had originally selected one of the four methods being studied during CHOICE enrollment.